TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Investor Investigation Concerning Possible Breaches Of Fiduciary Duties Announced

  • If you purchased shares of Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) and currently hold any of those NASDAQ:CYCC shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Cyclacel Pharmaceuticals Inc
Security
NASDAQ: CYCC

Summary

March 11, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) was announced over potential breaches of fiduciary duties by certain officers and directors at Cyclacel Pharmaceuticals.

The investigation by a law firm concerns whether certain Cyclacel Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.

Cyclacel Pharmaceuticals Inc reported that its annual Total Revenue rose from $1.08 million in 2013 to $1.73 million in 2014 while its Net Loss increased from $10.15 million in 2013 to $19.39 million in 2014.

Shares of Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) declined from $7.17 per share in November 2012 to as low as $0.30 per share on January 19, 2016.

Start Monitoring Your Investments